Curosurf Versus BLES in the Treatment of Preterm Neonates with Respiratory Distress Syndrome: A Randomized Clinical Trial
Open Access
- 27 April 2025
- journal article
- Published by Brieflands in Innovative Journal of Pediatrics
- Vol. 35 (3)
Abstract
Background: Two natural surfactants, Curosurf and BLES, are commonly used for the treatment of respiratory distress syndrome (RDS). Animal-derived surfactants have different pharmacological and biochemical features, and these differences might influence their clinical efficacy and complications. Objectives: The present study aimed to compare the clinical effectiveness and complications of Curosurf and BLES in the management of preterm neonates with RDS. Methods: This randomized clinical trial was conducted on 160 neonates with RDS and a gestational age of ≤ 32 weeks. Patients were randomly assigned to two intervention groups to receive either Curosurf (n = 80) or BLES (n = 80). Complications of prematurity, mortality, and the effectiveness of surfactant therapy were compared between the study groups. Results: There were statistically significant differences between the Curosurf group and the BLES group in the length of hospital stay (20.3 ± 14.4 vs. 27.3 ± 18.8 days, P = 0.01), number of surfactant injections (1.2 ± 0.4 vs. 1.4 ± 0.4, P = 0.006), and need for a second dose (21.2% vs. 41.2%, P = 0.005). In terms of complications, both groups showed no considerable differences. Conclusions: Compared to BLES, Curosurf may be more effective in the treatment of preterm neonates with RDS. Further clinical trials with robust designs and long-term follow-up are needed to compare these surfactants.Keywords
This publication has 32 references indexed in Scilit:
- Evolution of surfactant therapy for respiratory distress syndrome: past, present, and futurePediatric Research, 2016
- Comparison of efficacy and safety of two available natural surfactants in Iran, Curosurf and Survanta in treatment of neonatal respiratory distress syndrome: A randomized clinical trialContemporary Clinical Trials Communications, 2016
- Efficacy and safety of surfactant replacement therapy for preterm neonates with respiratory distress syndrome in low- and middle-income countries: a systematic reviewJournal of Perinatology, 2016
- Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome2015
- Secretory phospholipase A2 and neonatal respiratory distress: pilot study on broncho-alveolar lavageIntensive Care Medicine, 2008
- Biochemical and pharmacological differences between preparations of exogenous natural surfactant used to treat Respiratory Distress Syndrome: Role of the different components in an efficient pulmonary surfactantEuropean Journal of Pharmacology, 2007
- Unexplained Neonatal Respiratory Distress Due to Congenital Surfactant DeficiencyThe Journal of Pediatrics, 2007
- Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infantsRespiratory Medicine, 2007
- Comparison of three treatment regimens of natural surfactant preparations in neonatal respiratory distress syndromeEuropean Journal of Pediatrics, 2003
- An International Classification of Retinopathy of PrematurityArchives of Ophthalmology (1950), 1987